中华创伤杂志(英文版)2022,Vol.25Issue(1) :17-24.

Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with carbapenem-resistant klebsiella pneumonia (CrKP)

Ming Wu Zhi-Ye Zou Yan-Hong Chen Cong-Lin Wang Yong-Wen Feng Zhi-Feng Liu
中华创伤杂志(英文版)2022,Vol.25Issue(1) :17-24.

Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with carbapenem-resistant klebsiella pneumonia (CrKP)

Ming Wu 1Zhi-Ye Zou 2Yan-Hong Chen 2Cong-Lin Wang 3Yong-Wen Feng 2Zhi-Feng Liu3
扫码查看

作者信息

  • 1. Department of Critical Care Medicine and Hospital Infection Prevention and Control,Shenzhen Second People's Hospital,Shenzhen,518035,China
  • 2. Department of Critical Care Medicine,First Affiliated Hospital of Shenzhen University,Shenzhen 518035,China
  • 3. Department of Critical Care Medicine,General Hospital of Southern Theater Command of PLA,Guangzhou,510010,China
  • 折叠

Abstract

Purpose:COVID-19 is also referred to as a typical viral septic pulmonary infection by 2019-nCoV.However,little is known regarding its characteristics in terms of systemic inflammation and organ injury,especially compared with classical bacterial sepsis.This article aims to investigate the clinical charac-teristics and prognosis between COVID-19-associated sepsis and classic bacterial-induced sepsis.Methods:In this retrospective cohort study,septic patients with COVID-19 in the intensive care unit(ICU) of a government-designed therapy center in Shenzhen,China between January 14,2020 and March 10,2020,and septic patients induced by carbapenem-resistant klebsiella pneumonia (CrKP) admitted to the ICU of the Second People's Hospital of Shenzhen,China between January 1,2014 and October 30,2019 were enrolled.Demographic and clinical parameters including comorbidities,critical illness scores,treatment,and laboratory data,as well as prognosis were compared between the two groups.Risk factors for mortality and survival rate were analyzed using multivariable logistic regression and survival curve,respectively.Results:A total of 107 patients with COVID-19 and 63 patients with CrKP were enrolled.A direct com-parison between the two groups demonstrated more serious degrees of primary lung injury following 2019-nCoV infection (indicated by lower PaO2/FiO2),but milder systemic inflammatory response,lower sequential organ failure assessment score and better functions of the organs like heart,liver,kidney,coagulation,and circulation.However,the acquired immunosuppression presented in COVID-19 patients was more severe,which presented as lower lymphocyte counts (0.8× 109/L vs.0.9× 109/L).Moreover,the proportion of COVID-19 patients treated with corticosteroid therapy and extracorporeal membrane oxygenation was larger compared with CrKP patients (78.5% vs.38.1% and 6.5% vs.0,respectively) who required less invasive mechanical ventilation (31.6% vs.54.0%).The incidence of hospitalized mortality and length of ICU stay and total hospital stay were also lower or shorter in viral sepsis (12.1% vs.39.7%,6.5 days vs.23.0 days and 21.0 days vs.33.0 days,respectively) (all p < 0.001).Similar results were obtained after being adjusted by age,gender,comorbidity and PaO2/FiO2.Lymphocytopenia and high acute physiology and chronic health evaluation Ⅱ scores were common risk factors for in-hospital death.While the death cases of COVID-19 sepsis mostly occurred at the later stages of patients' hospital stay.Conclusion:Critical COVID-19 shares clinical characteristics with classical bacterial sepsis,but the degree of systemic inflammatory response,secondary organ damage and mortality rate are less severe.However,following 2019-nCoV infection,the level of immunosuppression may be increased and thus induce in more death at the later stage of patients' hospitalstay.

Key words

Clinical characteristics/Immunosuppression/Mortality/COVID-19/Carbapenem-resistant klebsiella pneumonia(CrKP)

引用本文复制引用

基金项目

PLA Logistics Research Project of China(18CXZ030)

PLA Logistics Research Project of China(CWH17L020)

PLA Logistics Research Project of China(17CXZ008)

Sanming Project of Medicine in Shenzhen(SZSM20162011)

Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project(20173357201815)

Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project(No 20193357003)

Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project(No 20203357014)

出版年

2022
中华创伤杂志(英文版)
中华医学会

中华创伤杂志(英文版)

CSTPCDCSCD
影响因子:0.608
ISSN:1008-1275
被引量4
参考文献量1
段落导航相关论文